PATENT CLAIM ANALYSIS

Application Number: 15936176
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-08
Patent Classification: ["514", "226500"]

Abstract:
Disclosed herein are compositions comprising a drug such as a triptan (e.g. rizatriptan) and/or an NSAID (e.g. meloxicam) in combination with a cyclodextrin and/or a carbonate or a bicarbonate. These compositions may be orally administered, for example, to improve the bioavailability or pharmacokinetics of the drug for the treatment of conditions such as pain.

Claim (Index 26):
The method of  claim 25 , wherein about 5 mg to about 20 mg of the rizatriptan is present in the dosage form based upon the weight of the rizatriptan in the free base form.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 90.0
- Lexical Diversity: 1.48837
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15902770', '15797955', '15132130', '15049488', '14280117']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8118679706769779
- 35 USC 102 Novelty (BERT): 0.5450817743719754
- Combined Prediction Score: 0.7851893510464776
- Mean Citation Score: 318.448196
- Max Citation Score: 422.23367
- Similarity Product: 298.4977444121319

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test